Emmaus Life Sciences Reports Q3 2022 Financial Results and Provides Business Update ...Middle East

PR Newswire - News
Emmaus Life Sciences Reports Q3 2022 Financial Results and Provides Business Update
TORRANCE, Calif., Nov. 14, 2022 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported on its results of operations and financial condition as of and for the three and nine...

Hence then, the article about emmaus life sciences reports q3 2022 financial results and provides business update was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Emmaus Life Sciences Reports Q3 2022 Financial Results and Provides Business Update )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News